Latest News

Sign up for our RSS Feed.
27 Apr 2015 NeurOp Announces Strategic Collaboration with Johnson & Johnson Innovation to St ... Read More
2 Oct 2014 NeurOp Receives Milestone Payment as Bristol-Myers Squibb Nominates NMDA Recepto ... Read More
About Us

Based in Atlanta, NeurOp was founded in 2002 by Raymond Dingledine, Ph.D., and Stephen Traynelis, Ph.D., both of the department of pharmacology at Emory University School of Medicine, and James McNamara, M.D., chairman of the neurobiology department at Duke University Medical Center. Through their collaboration, these researchers were able to translate years of rigorous investigation of a critical signaling pathway in the central nervous system into promising drug compounds.

NeurOp scientists are today refining these promising leads to create more effective and safe medicines for the treatment of major depression, neuropathic pain, ischemia and other indications. Our expertise in the neuropharmacology of drugs that interact with the NMDA receptor is evident in the strength of our Management Team and Scientific Founders & Board of Directors.